Clinical Trials Browser

Phase 2 × Leiomyosarcoma × Filgrastim × Clear all

NCT00004066 2013-03-07

Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma

Phase 2 Completed

GynecologicSarcoma

Leiomyosarcoma, Ovarian Neoplasms, Sarcoma